Rayban Sun Optics India Pvt
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
5- The company has delivered a poor sales growth of 3.87% over past five years.
- Company has a low return on equity of 12.7% over last 3 years.
- Earnings include an other income of Rs.16.5 Cr.
- Dividend payout has been low at 3.84% of profits over last 3 years
- Company has high debtors of 176 days.
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Sales | 45 | 60 | 74 | 104 | 144 |
| Expenses | 37 | 49 | 67 | 100 | 132 |
| Operating Profit | 8 | 10 | 8 | 5 | 12 |
| OPM % | 17% | 17% | 11% | 4% | 8% |
| Other Income | 1 | 0 | 1 | 5 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 1 | 0 | 1 |
| PBT | 7 | 9 | 7 | 8 | 11 |
| Tax % | 25% | 25% | 25% | 20% | 25% |
| Net Profit | 5 | 7 | 5 | 6 | 8 |
| EPS (₹) | 2.43 | 1.64 | 0.97 | 1.17 | 1.47 |
Profit & Loss
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 46 | 59 | 81 | 66 | 73 | 59 | 50 | 61 | 69 | 91 | 71 |
| Expenses | 34 | 47 | 60 | 50 | 58 | 35 | 26 | 25 | 36 | 50 | 40 |
| Operating Profit | 12 | 13 | 20 | 16 | 15 | 24 | 24 | 36 | 33 | 41 | 30 |
| OPM % | 25% | 21% | 25% | 24% | 21% | 41% | 48% | 60% | 47% | 45% | 43% |
| Other Income | 6 | 7 | 8 | 9 | 13 | 11 | 14 | 17 | 15 | 25 | 16 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 3 |
| PBT | 15 | 18 | 27 | 22 | 26 | 32 | 35 | 50 | 44 | 61 | 44 |
| Tax % | 34% | 35% | 35% | 35% | 34% | 35% | 32% | 33% | 33% | 37% | 34% |
| Net Profit | 10 | 12 | 17 | 15 | 17 | 21 | 24 | 34 | 30 | 39 | 29 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 12% | 0% | 0% |
Balance Sheet
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 23 | 23 | 23 |
| Reserves | 61 | 73 | 90 | 105 | 122 | 142 | 166 | 200 | 205 | 244 | 272 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 21 | 31 | 27 | 23 | 30 | 31 | 25 | 22 | 43 | 36 | 35 |
| Total Liabilities | 106 | 128 | 141 | 152 | 176 | 197 | 216 | 246 | 271 | 303 | 330 |
| Fixed Assets | 9 | 9 | 8 | 14 | 12 | 10 | 10 | 8 | 16 | 13 | 11 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 97 | 119 | 133 | 139 | 164 | 185 | 206 | 238 | 254 | 289 | 319 |
| Total Assets | 106 | 128 | 141 | 152 | 176 | 197 | 216 | 246 | 271 | 303 | 330 |
Cash Flow
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 6 | 4 | 15 | 7 | 11 | 17 | 19 | 8 | 19 | 14 | 8 |
| Investing | 11 | 3 | 4 | 1 | 7 | 5 | -29 | -6 | 6 | 28 | -49 |
| Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -26 | 0 | 0 |
| Net Cash Flow | 17 | 7 | 19 | 9 | 18 | 22 | -10 | 2 | -1 | 41 | -40 |
| Free Cash Flow | 5 | 3 | 14 | 0 | 9 | 14 | 19 | 8 | 16 | 9 | 5 |
| CFO/OP | 84 | 90 | 115 | 109 | 134 | 122 | 136 | 62 | 107 | 84 | 76 |
Ratios
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 116 | 115 | 105 | 104 | 111 | 106 | 83 | 125 | 132 | 116 | 176 |
| Inventory Days | 123 | 136 | 120 | 143 | 116 | 325 | 223 | 450 | — | 243 | 318 |
| Days Payable | 115 | 147 | 198 | 210 | 196 | 253 | 190 | 187 | — | 131 | 141 |
| Cash Conversion Cycle | 124 | 104 | 27 | 37 | 31 | 178 | 117 | 389 | 132 | 228 | 353 |
| Working Capital Days | 96 | 107 | 72 | 81 | 79 | 79 | 108 | 200 | 151 | 160 | 259 |
| ROCE % | — | 20% | 25% | 19% | 19% | 21% | 20% | 24% | 20% | 24% | 16% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Rayban Sun Optics India Pvt insights
29 extracted metrics + investor summaries across FY05–FY26.
Documents
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BAUSCHLOMB.md for Rayban Sun Optics India Pvt Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.